NCT04267978 2024-10-15
Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas
Beijing Sanbo Brain Hospital
Phase 2 Recruiting
Beijing Sanbo Brain Hospital
Beijing Sanbo Brain Hospital
Zhejiang Cancer Hospital